Assembly Biosciences (ASMB) Other Accumulated Expenses (2018 - 2026)

Assembly Biosciences' Other Accumulated Expenses history runs 9 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 26.97% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (down 26.97% YoY), while the FY2025 annual figure was $7.7 million, up 12.93% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $1.5 million, down from $7.7 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $7.7 million in Q4 2025, with the low at $1.5 million in Q1 2026.
• The 5-year median for Other Accumulated Expenses is $3.2 million (2023), against an average of $3.7 million.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses plunged 59.19% in 2024, then soared 92.81% in 2025.
• Assembly Biosciences' Other Accumulated Expenses stood at $3.1 million in 2022, then jumped by 83.98% to $5.7 million in 2023, then climbed by 19.46% to $6.9 million in 2024, then increased by 12.93% to $7.7 million in 2025, then plunged by 80.15% to $1.5 million in 2026.
• Business Quant data shows ASMB's Other Accumulated Expenses at $1.5 million in Q1 2026, $7.7 million in Q4 2025, and $3.1 million in Q3 2025.